Quantcast

CME Outfitters Announces New neuroscienceCME Webcast: ‘Advances in the Treatment of Schizophrenia: New Approaches’

October 20, 2010

Offered as a simultaneous webcast and telephone audioconference premiering Tuesday, November 16, 2010, from 12:00 p.m.-1:30 p.m. ET, the continuing education activity seeks to distinguish benefits and risks of various pharmacological therapies in the treatment of schizophrenia and provide strategies for use in clinical practice to improve functional outcome and overall quality of life for patients affected by schizophrenia.

Rockville, MD (PRWEB) October 19, 2010

CME Outfitters, LLC, (CMEO) an award-winning accredited provider of multidisciplinary continuing education (CE), is pleased to announce an upcoming neuroscienceCME Webcast titled “Advances in the Treatment of Schizophrenia: New Approaches.”

Offered as a simultaneous webcast and telephone audioconference premiering Tuesday, November 16, 2010, from 12:00 p.m.-1:30 p.m. ET, the continuing education activity seeks to distinguish benefits and risks of various pharmacological therapies in the treatment of schizophrenia and provide strategies for use in clinical practice to improve functional outcome and overall quality of life for patients affected by schizophrenia. This CE activity will also be available as an archived webcast, podcast, and teleconference shortly after the live webcast.

There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www.neuroscienceCME.com/PR501 and click the Register for Live Webcast icon.
Phone: Call 877.CME.PROS (877.263.7767).
Fax: Visit the activity details page at http://www.neuroscienceCME.com/PR501, print and complete the activity details form, and fax to 614.929.3600.

Statement of Need:
A critical component of recovery in schizophrenia is functional remission. Recovery requires effort on the part of patients and support from caregivers to bypass societal barriers and reach functional objectives. Clinicians must learn strategies to achieve functional remission, consistently measure functional change in their patients, and work with patients to raise the bar toward achieving functional remission. Clinicians must know specific distinctions in efficacies of antipsychotic agents.

As we increasingly broaden our treatment goals from an exclusive focus on effectiveness to improving quality of life, minimizing drug side effects and medical complications becomes a high priority of treatment. In addition, selection of an antipsychotic agent often involves a balance among optimal efficacy, safety, and tolerability for an individual patient.

This neuroscienceCME Webcast will address a comprehensive approach in the choice of antipsychotic agent and measurement of functioning in the treatment of schizophrenia. The activity will review the relationships among side effects, adherence, and medical morbidity. It will specifically address the side effect profiles of the new-generation agents while discussing strategies to minimize their side effects and medical risk.

Faculty:
Donald C. Goff, MD
Professor of Psychiatry
Harvard Medical School
Director, Schizophrenia Program
Massachusetts General Hospital
Boston, MA

Philip D. Harvey, PhD
Professor of Psychiatry and Behavioral Sciences
University of Miami Miller School of Medicine
Miami, FL

Learning Objectives:
At the end of this CE activity, participants should be able to:

  • Distinguish among efficacy and effectiveness profiles of different antipsychotic agents to optimize treatment selection.
  • Individualize treatment for patients with schizophrenia by balancing the relative experiences of each patient with side effects, medical morbidity, and medication adherence history.
  • Implement strategies to measure functional change and integrate functional remission into treatment goals for patients with schizophrenia.

Target Audience:
The activity is designed for physicians, physician assistants, nurses, nurse practitioners, psychologists, pharmacists, social workers, certified case managers, and other healthcare professionals with an interest in schizophrenia.

Financial Support:
Supported by an educational grant from Dainippon Sumitomo Pharma America, Inc. On April 1, 2010, DSPA merged with Sepracor Inc., creating one, united North American operation for our parent company, Dainippon Sumitomo Pharma Co., Ltd.

Credit Information:
The activity offers CE credit for:

  • Physicians (ACCME/AMA PRA Category 1â“¢)
  • Nurses (CNE)
  • Pharmacists (ACPE)
  • Psychologists (APA)
  • Social Workers (NASW)
  • Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date: Wednesday, November 16, 2011

Post-tests, credit request forms, and activity evaluations must be completed online at neuroscienceCME.com (click on the Testing/Certification link under the Activities tab–requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required).

About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site’s primary mission is to be the professional’s central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Clinical Compassâ“¢, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on “Subscribe to Clinical Compassâ“¢.”

Contact: Rachel Ellis
CME Outfitters, LLC
614.328.4506 direct
614.929.3600 fax

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2010/10/prweb4661124.htm


Source: prweb



comments powered by Disqus